Global Clinical Data Management System (CDMS) Market Overview

Global Clinical Data Management System (CDMS) Market size is expected to grow from USD 2.3 Billion in 2022 to USD 5.42 Billion by 2030, at a CAGR of 11.3% during the forecast period (2023–2030).

• A clinical data management system's (CDMS) goal is to make sure that all patient care and treatment data is organized, easily accessible, and safe. Healthcare professionals may remain on top of patient histories, drug allergies, test findings, and other pertinent data by using a CDMS. Healthcare providers may enhance interprofessional communication and better coordinate patient care by centrally keeping this data in a safe location.

• A Clinical Data Management System (CDMS) plays a pivotal role in clinical research by efficiently handling the gathering, arrangement, and supervision of data produced throughout clinical trials. Its utilization extends across the complete spectrum of a clinical study, encompassing study initiation, data collection, and analysis, as well as reporting. CDMS enables researchers to record and manage diverse clinical trial information, such as patient demographics, medical backgrounds, laboratory findings, and adverse events. This system guarantees the reliability of data and adherence to regulatory guidelines, and it fosters collaborative efforts among research teams through a centralized platform for data input and monitoring.

• The utilization of a clinical data management system (CDMS) offers a multitude of benefits. It elevates the precision and quality of data by mitigating errors associated with manual data entry in paper-based systems., CDMS enhances the traceability and auditability of data, a critical aspect of regulatory compliance during submissions and inspections. Additionally, it expedites the data cleaning process through automated validation checks, facilitating a more efficient and timelier database lock.

• Moreover, CDMS contributes to overall study efficiency by providing real-time access, monitoring, and reporting of data, thereby streamlining decision-making processes. In conclusion, the integration of CDMS not only enhances the dependability and authenticity of clinical trial data but also plays a pivotal role in generating robust evidence to advance medical knowledge and enhance patient outcomes.

Clinical Data Management System (CDMS) Market Trend Analysis:

Rising Number of Clinical Trials

• The Clinical Data Management System (CDMS) market is witnessing substantial growth, primarily driven by the increasing volume of global clinical trials. The pharmaceutical, biotechnology, and healthcare sectors are expanding their research and development efforts, creating a heightened demand for robust data management systems. The proliferation of clinical trials underscores a dedicated emphasis on advancing medical understanding, innovating new treatments, and enhancing patient outcomes.

• Clinical trials generate extensive datasets encompassing patient details, treatment results, and safety evaluations. Effectively managing this data is essential for upholding the integrity, precision, and compliance of clinical trial procedures. CDMS assumes a crucial role in simplifying the collection, storage, and analysis of data, thereby improving the overall efficacy of clinical trials. The growing intricacy of trials, coupled with stringent regulatory standards, highlights the necessity for advanced data management solutions.

• Therefore, the CDMS market is experiencing a surge in demand as organizations strive to implement cutting-edge systems that streamline data handling and contribute to the triumph of clinical research initiatives. In conclusion, the increasing prevalence of clinical trials serves as a key catalyst for the expansion of the clinical data management system market, underscoring the industry's dedication to advancing medical knowledge and enhancing healthcare outcomes.

Integration with Other Healthcare Technologies

• The expansion of the Clinical Data Management System (CDMS) market is significantly bolstered by the opportunity to integrate with other healthcare technologies. In the dynamic healthcare landscape, the seamless interoperability of various technologies has become crucial. The integration of CDMS with different healthcare systems, such as Electronic Health Records (EHRs), Health Information Exchanges (HIEs), and analytical tools, enhances the efficiency of data management in clinical trials. This integration promotes a comprehensive approach to patient care, streamlining information flow across platforms and ensuring a thorough understanding of patient health.

• Additionally, incorporating CDMS with emerging technologies like artificial intelligence (AI) and machine learning introduces advanced data analytics capabilities. These technologies offer valuable insights, predictive analytics, and real-time decision support, empowering researchers and clinicians to make well-informed decisions. The collaboration with telehealth solutions and wearable devices adds real-world, patient-generated data to the dataset, fostering a more patient-centric approach to clinical trials.

• As the healthcare industry undergoes a digital transformation, the integration of CDMS with diverse technologies not only improves data management but also positions the market for substantial growth by addressing the evolving needs of modern healthcare ecosystems. In conclusion, the integration with other healthcare technologies stands as a pivotal opportunity for the clinical data management system market, promising to transform data utilization and contribute to more effective and patient-centric clinical research.

Clinical Data Management System (CDMS) Market Segment Analysis:

Clinical Data Management System (CDMS) Market is Segmented Based on By Type, Deployment, Component, Application and End-User.

By Application, Pharma & Biopharmaceutical segment is expected to dominate the market during the forecast period.

• The pharmaceutical and biopharmaceutical sector emerges as the predominant segment within the Clinical Data Management System (CDMS) market. The intricate and highly regulated nature of research in pharmaceutical and biopharmaceutical fields underscores the imperative need for robust data management systems to uphold the integrity and compliance of clinical trials. CDMS assumes a crucial role in efficiently organizing the extensive and intricate data generated throughout the drug development process, encompassing patient information, treatment outcomes, and safety assessments.

• The perpetual pursuit of innovation, drug discovery, and adherence to stringent regulatory standards amplifies the demand for advanced data management solutions. As companies in the pharmaceutical and biopharmaceutical realms strive to optimize research efficiency and introduce novel therapies to the market, the CDMS market undergoes sustained growth, firmly positioning this sector as the primary catalyst in the ever-evolving domain of clinical data management.

Clinical Data Management System (CDMS) Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• The market for Clinical Data Management Systems (CDMS) is dominated by North America. Its renown stems from the region's robust pharmaceutical sector, sophisticated healthcare system, and high rate of clinical trials. In particular, the United States is home to a large number of biotech and pharmaceutical businesses that are actively engaged in substantial research and development projects, which has increased demand for advanced data management systems

• Moreover, the strict regulatory environment in North America emphasizes how important it is to handle clinical data effectively and legally, which drives up the use of CDMS systems. The region's commitment to innovation in healthcare and technology is essential to maintaining the growth of the CDMS market. While North America continues to serve as a hub for medical research and advancement, it solidifies its role as the primary driver and leader in the continually evolving realm of clinical data management.

Key Players Covered in Clinical Data Management System (CDMS) Market:

• Fortress Medical Systems(US)

• Ofni Systems (US)

• eClinical Solutions LLC (US)

• CIMS Global (US)

• Deep 6 AI (US)

• ACI Clinical (US)

• Perceptive Informatics (US)

• Medidata Rave (US)

• Forte Research Systems (US)

• Merative (US)

• ClinCapture (US)

• Veeva System (US)

• Oracle Corporation (US)

• Novaseek Research

• OpenClinica, LLC (US)

• Axiom Real-Time Metrics (Canada)

• Medrio (San Francisco)

• Ennov (France), and other major players.

Key Industry Development in The Clinical Data Management System (CDMS) Market:

• In June 2022, MMS Holdings, a data-focused Contract Research Organization (CRO) declared a strategic partnership with Medidata. The main view of this partnership is to provide clients with a full range of Medidata’s solutions for clinical data management (CDM) and decentralized clinical trial (DCT) technologies which consist of Medidata’s unified platform and Rave EDC.

• In April 2022, Ennov acquired MACRO from Elsevier, a supplier of advanced EDC (Electronic Data Capture) software for clinical research. The MACRO serves research institutions in Austria, Ireland, Spain, Sweden, Germany, and Switzerland. This acquisition is expected to help the company offer clinical trial and compliance solutions in the Europe region.

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BY TYPE (2016-2030)
   1. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. PAPER-BASED SYSTEMS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2016 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2016 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. ELECTRONIC DATA CAPTURING SYSTEMS
   5. HYBRID SYSTEMS
7. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BY DEPLOYMENT (2016-2030)
   1. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. ON-PREMISE
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2016 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2016 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. CLOUD-BASED
8. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BY COMPONENT (2016-2030)
   1. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. SOFTWARE
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2016 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2016 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. SERVICES
9. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BY APPLICATION (2016-2030)
   1. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. PHARMA & BIOPHARMACEUTICAL
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2016 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2016 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. MEDICAL DEVICE
   5. CONTRACT RESEARCH ORGANIZATIONS
   6. ACADEMIC & RESEARCH INSTITUTIONS
10. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BY END-USER (2016-2030)
    1. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET SNAPSHOT AND GROWTH ENGINE
    2. MARKET OVERVIEW
    3. HOSPITALS
       1. Introduction And Market Overview
       2. Historic And Forecasted Market Size in Value (2016 – 2030F)
       3. Historic And Forecasted Market Size in Volume (2016 – 2030F)
       4. Key Market Trends, Growth Factors And Opportunities
       5. Geographic Segmentation Analysis
    4. CLINICS
    5. RESEARCH LABORATORIES
11. COMPANY PROFILES AND COMPETITIVE ANALYSIS
    1. COMPETITIVE LANDSCAPE
       1. Competitive Positioning
       2. Clinical Data Management System (CDMS) Market Share By Manufacturer (2022)
       3. Industry BCG Matrix
       4. Heat Map Analysis
       5. Mergers & Acquisitions
    2. FORTRESS MEDICAL SYSTEMS
       1. Company Overview
       2. Key Executives
       3. Company Snapshot
       4. Role of the Company in the Market
       5. Sustainability and Social Responsibility
       6. Operating Business Segments
       7. Product Portfolio
       8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
       9. Key Strategic Moves And Recent Developments
       10. SWOT Analysis
    3. OFNI SYSTEMS (US)
    4. ECLINICAL SOLUTIONS LLC (US)
    5. CIMS GLOBAL (US)
    6. DEEP 6 AI (US)
    7. ACI CLINICAL (US)
    8. PERCEPTIVE INFORMATICS (US)
    9. MEDIDATA RAVE (US)
    10. FORTE RESEARCH SYSTEMS (US)
    11. MERATIVE (US)
    12. CLINCAPTURE (US)
    13. VEEVA SYSTEM (US)
    14. ORACLE CORPORATION (US)
    15. NOVASEEK RESEARCH
    16. OPENCLINICA, LLC (US)
    17. AXIOM REAL-TIME METRICS (CANADA)
    18. MEDRIO (SAN FRANCISCO)
    19. ENNOV (FRANCE)
12. GLOBAL CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Type
       4. Historic And Forecasted Market Size By Deployment
       5. Historic And Forecasted Market Size By Component
       6. Historic And Forecasted Market Size By Application
       7. Historic And Forecasted Market Size By End-User
       8. Historic And Forecasted Market Size By Country
          1. USA
          2. Canada
          3. Mexico
    3. EASTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Russia
          2. Bulgaria
          3. The Czech Republic
          4. Hungary
          5. Poland
          6. Romania
          7. Rest Of Eastern Europe
    4. WESTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Germany
          2. United Kingdom
          3. France
          4. The Netherlands
          5. Italy
          6. Spain
          7. Rest Of Western Europe
    5. ASIA PACIFIC
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. China
          2. India
          3. Japan
          4. South Korea
          5. Malaysia
          6. Thailand
          7. Vietnam
          8. The Philippines
          9. Australia
          10. New-Zealand
          11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Turkey
          2. Bahrain
          3. Kuwait
          4. Saudi Arabia
          5. Qatar
          6. UAE
          7. Israel
          8. South Africa
    7. SOUTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Brazil
          2. Argentina
          3. Rest of South America
13. INVESTMENT ANALYSIS
14. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET COMPETITIVE RIVALRY
TABLE 005. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET THREAT OF NEW ENTRANTS
TABLE 006. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET THREAT OF SUBSTITUTES
TABLE 007. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BY TYPE
TABLE 008. PAPER-BASED SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 009. ELECTRONIC DATA CAPTURING SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 010. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BY APPLICATION
TABLE 011. PHARMA & BIOPHARMACEUTICAL MARKET OVERVIEW (2016-2028)
TABLE 012. MEDICAL DEVICE MARKET OVERVIEW (2016-2028)
TABLE 013. OTHER MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY APPLICATION (2016-2028)
TABLE 016. N CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY APPLICATION (2016-2028)
TABLE 019. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY APPLICATION (2016-2028)
TABLE 022. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY APPLICATION (2016-2028)
TABLE 025. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY APPLICATION (2016-2028)
TABLE 028. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY COUNTRY (2016-2028)
TABLE 029. FORTRESS MEDICAL SYSTEMS (MINNESOTA): SNAPSHOT
TABLE 030. FORTRESS MEDICAL SYSTEMS (MINNESOTA): BUSINESS PERFORMANCE
TABLE 031. FORTRESS MEDICAL SYSTEMS (MINNESOTA): PRODUCT PORTFOLIO
TABLE 032. FORTRESS MEDICAL SYSTEMS (MINNESOTA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. OFNI SYSTEMS (US): SNAPSHOT
TABLE 033. OFNI SYSTEMS (US): BUSINESS PERFORMANCE
TABLE 034. OFNI SYSTEMS (US): PRODUCT PORTFOLIO
TABLE 035. OFNI SYSTEMS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. DEEP 6 AI (US): SNAPSHOT
TABLE 036. DEEP 6 AI (US): BUSINESS PERFORMANCE
TABLE 037. DEEP 6 AI (US): PRODUCT PORTFOLIO
TABLE 038. DEEP 6 AI (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. ACI CLINICAL (US): SNAPSHOT
TABLE 039. ACI CLINICAL (US): BUSINESS PERFORMANCE
TABLE 040. ACI CLINICAL (US): PRODUCT PORTFOLIO
TABLE 041. ACI CLINICAL (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. PERCEPTIVE INFORMATICS (US): SNAPSHOT
TABLE 042. PERCEPTIVE INFORMATICS (US): BUSINESS PERFORMANCE
TABLE 043. PERCEPTIVE INFORMATICS (US): PRODUCT PORTFOLIO
TABLE 044. PERCEPTIVE INFORMATICS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. MEDIDATA RAVE (US): SNAPSHOT
TABLE 045. MEDIDATA RAVE (US): BUSINESS PERFORMANCE
TABLE 046. MEDIDATA RAVE (US): PRODUCT PORTFOLIO
TABLE 047. MEDIDATA RAVE (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. FORTE RESEARCH SYSTEMS (US): SNAPSHOT
TABLE 048. FORTE RESEARCH SYSTEMS (US): BUSINESS PERFORMANCE
TABLE 049. FORTE RESEARCH SYSTEMS (US): PRODUCT PORTFOLIO
TABLE 050. FORTE RESEARCH SYSTEMS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. IBM WATSON HEALTH (CAMBRIDGE): SNAPSHOT
TABLE 051. IBM WATSON HEALTH (CAMBRIDGE): BUSINESS PERFORMANCE
TABLE 052. IBM WATSON HEALTH (CAMBRIDGE): PRODUCT PORTFOLIO
TABLE 053. IBM WATSON HEALTH (CAMBRIDGE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. CLINCAPTURE (US): SNAPSHOT
TABLE 054. CLINCAPTURE (US): BUSINESS PERFORMANCE
TABLE 055. CLINCAPTURE (US): PRODUCT PORTFOLIO
TABLE 056. CLINCAPTURE (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. MEDRIO (SAN FRANCISCO): SNAPSHOT
TABLE 057. MEDRIO (SAN FRANCISCO): BUSINESS PERFORMANCE
TABLE 058. MEDRIO (SAN FRANCISCO): PRODUCT PORTFOLIO
TABLE 059. MEDRIO (SAN FRANCISCO): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. NOVASEEK RESEARCH (SOUTH SAN FRANCISCO): SNAPSHOT
TABLE 060. NOVASEEK RESEARCH (SOUTH SAN FRANCISCO): BUSINESS PERFORMANCE
TABLE 061. NOVASEEK RESEARCH (SOUTH SAN FRANCISCO): PRODUCT PORTFOLIO
TABLE 062. NOVASEEK RESEARCH (SOUTH SAN FRANCISCO): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 063. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 064. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 065. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY TYPE
FIGURE 012. PAPER-BASED SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 013. ELECTRONIC DATA CAPTURING SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 014. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY APPLICATION
FIGURE 015. PHARMA & BIOPHARMACEUTICAL MARKET OVERVIEW (2016-2028)
FIGURE 016. MEDICAL DEVICE MARKET OVERVIEW (2016-2028)
FIGURE 017. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY COUNTRY (2016-2028)